mortality/aging
• 5-7 day-old mice treated with one dose of DMBA succumb to skin and lung cancers (18/42 mice) with median survival of 28.6 weeks compared to wild-type mice which remain cancer-free for >40 weeks
|
digestive/alimentary system
• polyps are present throughout gastrointestinal tract, including the stomach and colon
|
colon polyps
(
J:78818
)
• at 43 weeks, mice present with gastrointestinal obstruction
|
neoplasm
• one animal exhibited a benign serous cyadenoma of the pancreas, and 2 showed asymptomatic benign uterine epithelial tumors, but no other neoplasms were observed in mutants
(J:78818)
• mice have reduced cancer-free survival (28.6 weeks) relative to wild-type (>40 weeks)
(J:131037)
• mutants are sensitized to squamous cell carcinoma compared to wild-type
(J:131037)
|
• 5-7 day-old mice treated with one dose of DMBA (to promote development of lymphomas, sarcomas and lung adenomas) develop invasive skin and lung cancers not seen in wild-type mice
|
• polyps present as mucosal hamartomas without dysplastic or adenomatous changes
|
homeostasis/metabolism
• 5-7 day-old mice treated with one dose of DMBA (to promote development of lymphomas, sarcomas and lung adenomas) develop invasive skin and lung cancers not seen in wild-type mice
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Peutz-Jeghers syndrome | DOID:3852 |
OMIM:175200 |
J:78818 , J:131037 |